Escolar Documentos
Profissional Documentos
Cultura Documentos
Manuscript Draft
Manuscript Number:
Title: Diasmatomyelia (split cord malformations)
Our Experience
Cover Letter
By accepting this manuscript for review, [publisher name] accepts these terms and agrees
that the terms in this letter are paramount and supersede any provisions in any publication
agreement for this article, already signed or to be signed at a later date, that may conflict.
_________________________________________________
(Signature of corresponding author on behalf of all authors)
*Clinical Guidelines
TABLE 1. GUIDELINES FOR THE REPORTING OF CLINICAL RESEARCH DATA IN THE JOURNAL
OF PEDIATRIC SURGERY
Methods:
Reported
Not
Applicable
Reporting Detail
The number and practice type of all institutions where cases were performed
The number of surgeons who actually operated in the study (& relative number of cases for each)
The prior experience of participating surgeons in performing the reported intervention
The precise timeline during which all patients were treated in the study(i.e. Jan 1995 to March
1998)
1
2
25 years
January 2013 to
June 2014
A clear description of how patients were selected into the study. This should include relevant
inclusion and/or exclusion criteria.
Included were
having first
surgery all oother
were excluded
NA
18
Yes standard
criteria
yes
Yes for TYPE I
and TYPE II
The number of eligible patients at the study sites excluded during the timeline of the study
A clear description of the study population from which the patients were selected
A clear description of the relevant diagnostic criteria used to identify cases
A clear description of critical aspects of operative technique and perioperative care
Statement as to whether any attempts were made to standardize operative technique or perioperative
care (and how this was accomplished)
Results:
Reported
Not
Applicable
yes
yes
NA
YES
Lost to follow up
Reporting Detail
The range and mean of all relevant demographic and baseline variables
The range and median (not mean) for length of follow-up reporting
Relevant outcome variables are presented with appropriate measures of range and variability
(i.e. standard deviation)
Methods for measuring outcomes of interest are clearly described
Statement regarding whether any data is missing (and how missing data is addressed in the analysis
of outcome variables)
Number and appropriate details regarding all complications
YES
Additional Details for Studies Reporting More Than One Treatment Group (e.g. Controls):
Reported
Not
Applicable
NA
NA
NA
NA
NA
NA
NA
Reporting Detail
Mean and range for all relevant demographic and baseline variables for all treatment groups
The range and median (not mean) for length of follow-up reporting for each treatment group
A precise timeline during which all patients were treated for each group
Outcome variables being compared between groups are presented with appropriate measures of
variability (e.g. standard deviation)
Measures to type II error (P-values) for comparison statistics are presented with actual values if
P=.01 or larger (e.g. P=NS and P<.05 are not acceptable)
A description of how patients were selected into each treatment group
A statement is made as to whether the same surgeons operated on patients from different treatment
groups
Manuscripts concerning clinical research should follow a uniform set of reporting guidelines. The guidelines, listed above, were developed from
sound clinical research principles and are designed to improve the reporting accuracy of clinical data pertaining to surgical conditions. With
more accurate and transparent reporting of study methodology and outcomes data, readers of the Journal will be better able to gauge the relevance
of reported results to their own clinical practice. Although not all of the recommended reporting guidelines are applicable to every clinical study,
it is important that all details relevant to your study are clearly reported in the manuscript. Please check the appropriate boxes to verify
compliance with these guidelines and submit with the manuscript. Compliance with these guidelines will be considered by the editor in the final
decision regarding publication of your manuscript.
*Title Page
Our Experience
Umar Farooq, Sami Ur Rehman, Muhammad Nawaz,
Prof. Khaleeq u Zaman.
*Abstract
Our Experience
Umar Farooq, Sami Ur Rehman, Muhammad Nawaz,
Prof. Khaleeq u Zaman.
Department of Neurosurgery, Pakistan Institute of medical sciences,
Islamabad, Pakistan.
Abstract
Conclusions. The authors present 18 cases in one and half year. The
patients with dermal manifestations should be referring for neurosurgical
evaluation, prompt management before developing any other manifestations.
Awareness program for pediatric physicians and general public should be done for
better outcomes. Especially Parents should be counseled regarding folic acid
supplement in future. A multicenter large study carried out to answer the
challenges.
. Neurosurgery
*Manuscript
Click here to view linked References
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
18 (100%)
Spina bifida
4 (22.22%)
Scoliosis
2(11.11%)
Orthopedic lower
limbs deformity
9 (50%)
15 (83.33%)
Trophic ulcers
3 (16.66%)
15 (83.33%)
Imaging Studies
Magnetic resonance imaging of the
spine (for type and level of split, level of the
conus medullaris, thickness of the terminal
filum, presence of other associated tethering
elements, and syringomyelia) was performed,
along with a screening MR imaging study of the
brain and craniovertebral junction to look for
hydrocephalus, Chiari malformation, and
syringomyelia if symptoms were present. Plain
x-ray films of the spine were obtained to assess
for kyphoscoliosis and vertebral or rib
anomalies.
15 (83.33%)
Sensory
15 (83.33%)
Autonomic
10 (55.55%)
10 (55.55%)
Neurologically intact
3 (16.66%)
Surgical Procedures
Type I SCM.
A careful laminectomy or laminotomy
was performed around the attachment of rigid
septum. A laminotomy was used in patients with
well-formed laminae or in those who needed
exposure of the cord above or below the
dysraphic spine. The spur was then dissected
extradurally between the two dural sleeves and
removed piecemeal by using small rongeurs.
Fibrous adhesions were excised and dural
sleeves resected. The dura mater was opened
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
14 (77.77%)
Dimple
8 (44.44%)
Dermal Sinus
6 (33.33%)
Subcutaneus lipoma
5 (27.77%)
5 (27.77%)
Scoliosis
2 (11.11%)
Pes planus
2 (11.11%)
No orthopedics
deformity
9 (50%)
Imaging Findings
7 (38.88%)
Type II
11 (61.11%)
Cervical
0 (0%)
Dorso-lumbar
10 (55.55%)
Dorsal
4 (22.22%)
Lumbar
4 (22.22%)
Intraoperative Findings
There were four lumbar SCMs and 14
thorocolumbar SCMs in our series. In seven
patients the spur arose dorsally from the surface
of the neural arch. Various other lesions causing
tethering were observed, including a thick or
tight terminal filum, intradural lipoma, dermoid
or dermal sinus tract. Myelomeningoceles
manqu arising from the paramedian dorsal
surface of the hemicords projecting dorsally and
caudally from their point of origin from the cord
and attaching or penetrating the dura caudally
were noted in 5 (77.42%) of 7 cases of SCM
Type I and in 9 (81.81%) of 98 cases of Type
II. These bands constitute an important cause of
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
fresh
neurological
Parame
ter
Num
ber of
cases
Impro
ved
Deterior
ated
Unchan
ged
Motor
15
14
Nil
Sensor
y
15
14
Nil
Sphinct
ers
10
Nil
Patient Outcome
All of the patients were followed up 2
weeks after discharge and again at 3- to 6months intervals. Of the symptomatic patients,
14 (77.77%) showed improvement in motor
power, 14 (77.77%) of 15 improved with regard
to sensory symptoms, and 9 (90%) of 10
regained continence. Significant healing of
trophic ulcers was seen in 1 (50%) of 2 patients.
Neurological status was static in 1 (5.55%) of 18
patients. No patients showed neurological
deterioration. Neurological deficits improved
gradually. Three patients had permanent deficits,
and the one did not improved after 6 months of
follow up. Two patients were lost to follow up.
(Table 6). Postoperative complications were
present in 4 patients (22.22%) and two patients
(11.11%) had wound infections. All of these
issues were managed conservatively, and the
wounds healed well. Urinary tract infections
developed in 2 patients (11.11%). There were no
operative deaths. Among the symptomatic
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
Conclusions
Split cord malformations are rare
anomalies of the spinal cord, and we present the
largest prospective series so far reported in the
world literature. The risk of neurological deficits
developing increases with age. We recommend
prophylactic surgery for all asymptomatic
patients with SCM. Cutaneous markers should
be an important pointer for investigations for
occult spinal dysraphism, which was present in
100% of the patients in our series. All of the
patients with congenital and progressive
scoliosis should be screened with MR imaging.
The entire neuraxis should be evaluated and any
tethering lesions found should be simultaneously
treated at the time of the first surgery. Surgery
must be planned meticulously according to the
SCM type. Parents, pediatricians and
gynecologists should be counseled regarding
use folic acid during pregnancy.
References
1. Chandra PS, Kamal R, Mahapatra AK: An
unusual case of a dorsally situated bony spur
in a lumbar split cord malformation.
PediatrNeurosurg 31:4952, 1999
2. Colak A, zcan OE, Erbengi A:
Diastematomyelia in pediatric age. A
retrospective study of 15 cases. J
PediatrNeurosci 4:296300, 1988
3. David KM, Copp AJ, Stevens JM, Hayward
RD, Crockard HA: Split cervical spinal cord
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
*References
References
1. . Neurosurgery 31: Chandra PS, Kamal R, Mahapatra AK: An unusual case of a dorsally
situated bony spur in a lumbar split cord malformation. PediatrNeurosurg 31:4952, 1999
2. Colak A, zcan OE, Erbengi A: Diastematomyelia in pediatric age. A retrospective study of 15
cases. J PediatrNeurosci 4:296300, 1988
3. David KM, Copp AJ, Stevens JM, Hayward RD, Crockard HA: Split cervical spinal cord with
Klippel-Feil syndrome: seven cases. Brain 119:18591872, 1996
4. Dias MS, Pang D: Split cord malformations. NeurosurgClin N Am 6:339358, 1995
5. Ersahin Y, Mutluer S, Kocaman S, Demirtas E: Split spinal cord malformations in children. J
Neurosurg 88:5765, 1998
6. Goldberg C, Fenelon G, Blake NS, Dowling F, and Regan BF: Diastematomyelia: a critical
review of the natural history and treatment. Spine 9:367372, 1984
7. Gower DJ, Del Curling O, Kelly DL Jr, Alexander E Jr: Diastematomyelia40-year experience.
Pediatric Neurosci 14:9096, 1988
8. Guthkelch AN, Hoffman GT: Tethered spinal cord in association with Diastematomyelia.
SurgNeurol 15:352354, 1981
9. Humphreys RP, Hendrick EB, Hoffman HJ: Diastematomyelia. ClinNeurosurg 30:436456, 1983
10. Jindal A, Kansal S, Mahapatra AK: Split cord malformation with partial eventration of
diaphragm. Case report. J Neurosurg 93 (2 Suppl):309311, 2000
11. Jindal A, Mahapatra AK: Split cord malformationsa clinical study of 48 cases. Indian Pediatr
37:603607, 2000
12. Keim HA, Greene AF: Diastematomyelia and scoliosis. J Bone Joint Surg Am 55:14251435,
1973
13. Miller A, Guille JT, Bowen JR: Evaluation and treatment of diastematomyelia. J Bone Joint
Table/Figure Legends
18 (100%)
4 (22.22%)
2(11.11%)
9 (50%)
15 (83.33%)
3 (16.66%)
15 (83.33%)
15 (83.33%)
15 (83.33%)
10 (55.55%)
10 (55.55%)
3 (16.66%)
14 (77.77%)
8 (44.44%)
6 (33.33%)
5 (27.77%)
5 (27.77%)
2 (11.11%)
2 (11.11%)
9 (50%)
7 (38.88%)
11 (61.11%)
0 (0%)
10 (55.55%)
4 (22.22%)
4 (22.22%)
Table 6. Outcome
Parameter
Motor
Sensory
Sphincters
Number of cases
15
15
10
Improved
14
14
7
Deteriorated
Nil
Nil
Nil
Unchanged
1
1
3
List the names of any proprietary entities producing marketing, re-selling, or distributing health care goods or services consumed by,
or used on patients with which you or your spouse/partner have, or have had, a relevant financial relationship within the past 12
months.
Explain what you or your spouse/partner received (ex: salary, honorarium etc).
Specify your role.
Nature of Relevant Financial Relationship
Commercial Interest
(Include all those that apply)
What I or spouse/partner
My role
received
Example: Company X
Honorarium
Speaker
What was received: Salary, royalty, intellectual property My Role(s): Employment, management position,
rights, consulting fee, honoraria, ownership interest, (e.g., independent contractor (including contracted research),
stocks, stock options or other ownership interest,
consulting, speaking and teaching, membership on advisory
excluding diversified mutual funds), or other financial
committees or review panels, board membership, and other
benefit.
activities.
Through our review process, should it be determined that a bias is apparent within the content of the article, you will be requested to revise
your manuscript prior to publication.
If your article describes the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or
drug or unapproved usage, it is your responsibility to disclose this information within the manuscript.
Glossary of Terms
Commercial Interest
A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on,
patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights,
consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or
other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor
(including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership,
and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME
activity to include financial relationships of a spouse or partner.
Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceeding the time that the individual is being
asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant.
Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines relevant financial
relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a
commercial interest with which he/she has a financial relationship.